© Versita Sp. z o.o. In the current work, iron oxide magnetic nanoparticles (MNP's) were synthesized by thermal decomposition of Fe(acac) 3 -(iron acetylacetonate) compounds in high-boiling organic solvents containing stabilizing surfactants and examined as possible agents for magnetic hyperthermia treatment, according to their structural, magnetic and heating properties. Three different cancer cell lines (DA3, MCF-7 and HeLa cell lines) were used to assess the suitability of the MNP's. The experimental results proved that the synthesized MNPs are non-toxic and the uptake efficiency was extremely good. Further, from in vitro hyperthermia results, very fast thermal response was observed (reaching hyperthermia levels in less than 200 s), which minimize the duration of the cell and human body exposure in a high frequency AC external magnetic field.
Introduction
The word hyperthermia, as a term has its roots in the Greek word «Υπερθερμία», which means, the generation of heat in high level. The standard therapies for cancer treatment are based mainly on chemotherapy, radiotherapy and direct surgery. Sometimes a combination of these techniques is preferred [1] . In order for the cancer treatment to become more efficient, the oncologists use heat treatment in combination with the above methods. By performing heat treatment procedures, cancer cells are made more vulnerable to these therapies [2] . A complete and effective cancer therapy has to maximize the therapeutic efficiency while minimizing any side effects to the adjacent healthy tissues [3] . Hyperthermia treatment can force the cancer cells to be destroyed, by increasing the temperature of the cancerous tissue to 42ºC [4] [5] [6] . Hyperthermia can be considered a therapy because the increase of temperature locally within the tumor up to 42ºC destroys cancer cells, driving them to apoptosis [7] . Hyperthermia is also a viable method, when tumors have not metastasized and their regions are well known. Further, it is favorable when a tumor cannot be surgically removed [8] . Depending on the temperature, hyperthermia can be classified into two different types: 1) Moderate Hyperthermia, where the temperature within the tissues is in between 41-46ºC [9] and 2) Thermoablation, where the temperature within the tissues is from 46-50ºC, which yields widespread necrosis, coagulation or carbonization [10] . The efficiency of the hyperthermia treatment depends on the level of the temperature generated, the duration of exposed and the type of the cancer cells [11] .
Magnetic hyperthermia is considered a powerful and promising technique which has the potential to be a practical cancer therapy [12] . This is because the side effects of such a therapy are very low, compared with other cancer treatments [13] . The treatment by using magnetic hyperthermia starts with the dispersion of magnetic nanoparticles (MNP's) throughout the target
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In vitro magnetic hyperthermia response of iron oxide MNP's incorporated in DA3, MCF-7 and HeLa cancer cell lines tissue, followed by the application of an AC magnetic field, with high frequency and strength. This procedure makes the MNPs dissipate energy due to magnetic loses (hysteresis for ferromagnetic particles and thermal loses for superparamagnetic nanoparticles) [14] [15] [16] [17] [18] [19] [20] . This thermal energy is very efficient and homogeneous all over the tissue volume [21] .
Magnetic hyperthermia has a numerous of advantages compared to the conventional hyperthermia treatment which are summarized: a) Cancer cells can absorb MNPs [10] , b) MNPs can easily delivered to tumors by using of specific ligands, c) the delivery of MNPs is achieved by numerous drug delivery routes [22] , d) MNPs can easily pass capillary vessels and be delivered to tumors due to their small size [23] . The dissipation heat power of the MNPs depends on several intrinsic and extrinsic properties: MNPs shape, size, crystallity, material type, surface functionalization, particle concentration, interaction and agglomeration [24] . Magnetic fluid hyperthermia is a technique where the MNPs are dispersed into water or any hydrocarbon fluid. The pH of such fluid should be neutral and must have physiological salinity [25] . The biocompatibility of both the fluid and MNPs must be considered, because this is one of the most critical issues of magnetic fluid hyperthermia [17] .
The mechanism of heat generation in a magnetic nanoparticle can be attributed to two different phenomena: Relaxation and Hysteresis loss. The hysteresis loss is a phenomenon presented in ferromagnetic nanoparticles while the dominant energy loss mechanism for superparamagnetic nanoparticles is magnetic relaxation [26] . Relaxation mechanism is of two different types: Neel and Brownian relaxation [27] . Generally, the heat generation through Neel relaxation is due to rapidly occurring changes in the direction of magnetic moments relative to the crystal lattice, where the Brownian relaxation is due to physical rotation of the particles inside a medium, and it's hindered by the viscosity that counters the movement of the particles [28] . These two relaxation mechanisms have respective time constants t B and t N and occur simultaneously in a particle. The total effective particle relaxation time is t rel = t B t N / (t B + t N ) [29, 30] .
According to the Neel model, the magnetic moment inside a particle rotates according to the external magnetic field, when the thermal energy (k B T) of the particle exceeds the magnetic anisotropy energy (k a V m ) and the relaxation time is given by t N = √π
. Brownian relaxation occurs via the rotation of the entire particle due to the torque exerted by an AC magnetic field and t B = 3n(Vn/ k B T) [31] . The absorption efficiency of a material in order to generate heat when it is exposed to an AC external magnetic field is measured in terms of Specific Absorption Rate (SAR) or Specific Loss Power (SLP). These terms are used to define the quantity of magnetic energy transformed into heat [32] . These terms may vary by orders of magnitude due to their dependence on structural and magnetic properties of the particles and the amplitude and the frequency of the AC external field [33] . SAR is computed by the initial slope of the measured data [34] . This index is a function of temperature and is expressed in W gr -1 of magnetic element, and this factor is crucial for clinical purposes because the better the heat generation efficiency, the smaller the dose that has to be injected inside the body of the patient [35] . The SAR factor is given by: (SAR) = (1/m MNP ) C(ΔΤ/Δt), where C is the heat capacity of the material [36] [37] [38] .
Over [45] . Monodisperse magnetic nanocrystals with relatively small size can be synthesized through the thermal decomposition of a precursor in high-boiling organic solvents, which contains stabilizing surfactants [46] . Hyeon et al. [47] reported the formation of monodisperse γ-Fe 2 O 3 nanocrystals with a size of 13nm from the decomposition of iron pentacarbonyl at 100ºC in a mixture of octy-ether and oleic acid. Sun et al. [48] succeeded in the synthesis of monodispered magnetite nanopaticles using Fe(acac) 3 as starting material. Li et al. [49] , reported the synthesis of monodisperse oleic acid coated Fe 3 O 4 nanoparticles with thermal decomposition of Fe(acac) 3 in the presence of oleic acid. Kluchova et al. [50] prepared super paramagnetic maghemite nanoparticles (15-20nm) by using one step thermal decomposition of iron (II) acetate in air at 400 0 C. Habibi et al. [51] prepared single-phase a-Fe(III) oxide nanoparticles by thermal decomposition of five different precursors. They measured the crystallite size of the pure a-Fe 2 O 3 phase was calculated using Scherrer's equation and they were within a narrow range of 29-38 nm.
In the current work, hyperthermia response of nanostructured iron oxides due to their potential applications in biomedicine was studied. Iron oxide nanoparticles were synthesized with thermal decomposition of Fe(acac) 3 -(iron acetylacetonate), and used, with the aim of inducing hyperthermia in cancer cells. Two samples were selected over a series of 4 samples, based on their size (10-12 nm), their high hyperthermia response (ΔT > 20-30 o C), their magnetic properties (M s = 65 emu g -1 ) and the fact that they exhibit superparamagnetic features at room temperature. The magnetic nanoparticles (MNPs) were added to cell cultures, e.g. the cervical cancer cell lines HeLa and the mammary adenocarcinoma cell lines DA3 and MCF-7. An initial concentration of 2 mg mL -1 of MNP's in the solution was added to 10.000-50.000 of cells and left over a period of 24 h and 48 h for cellular uptake. To assay the percentage of cells that have uptaken the magnetic nanoparticles, a magnetic field cell separator MACS was used. The cells collected present high viability (more than 90%) after incubating 2 mg mL -1 of MNPs, alluding to the fact that the produced MNPs are not toxic. Proliferation and cytotoxicity tests were performed before and after hyperthermia in order to estimate the percentage of cells killed by heat induction. The magnetic field of 25.46 kA m -1 resulted in reaching hyperthermia levels in time intervals less than 200 s. Viability measurements following hyperthermia showed that the majority of cancer cells died with only a few cells surviving the heat induction (0-10%).
Experimental procedure

Synthesis and characterization of MNP's
Synthesis of MNP's
Iron oxide nanoparticles were synthesized by thermal decomposition of Fe(acac) 3 -(iron acetylacetonate) compounds in high-boiling organic solvents containing stabilizing surfactants. Four different samples of colloidal dispersions consisting of iron oxides were prepared with the following procedures: «Sample-1»: Fe(acac) 3 (2.5 mmol) and triethylene glycol (TEG) used both as surfactant and reductive were mixed in Ar atmosphere under vigorous stirring by a mechanical agitator. The mixture was heated at 190ºC for 30 min and then heated to reflux at 280ºC for another 90 min. The black precipitate was separated by washing with ethanol and then centrifuging. Finally, the product was dispersed into n-hexane.
«Sample-2»: Fe(acac) 3 (2.5 mmol) was mixed with 20 g of triethylene glycol (TEG) as the surfactant and NaBH 4 (2mmol) as the reductive. The mixture was heated at 190ºC for 30 min and then heated to reflux at 280ºC for another 90 min. The black precipitate was separated by washing with ethanol and then centrifuging. Finally, the product was dispersed into n-hexane.
«Sample-3»: Fe(acac) 3 (2.5 mmol) was mixed with 20 g of polyethylene glycol (PEG-800) as surfactant and NaBH 4 (2 mmol) as the reductive. The mixture was heated at 180 0 C for 30 min and then heated again to reflux at 250ºC for additional 90 min. The black product was obtained upon adding excess of ethanol and centrifuging. Finally the product was dispersed into n-hexane.
«Sample-4»: Fe(acac) 3 (2.5 mmol) was mixed with 20 g of decanethyol+ triethylene glycol as the surfactants and with NaBH 4 (2mmol) as the reductive. The mixture was heated at 180ºC for 30 min and then heated again to reflux at 250ºC for additional 90 min. The black product was obtained upon adding an excess of ethanol and centrifuging. Finally the product was dispersed into n-hexane.
Structural and morphological characterization of magnetic nanoparticles
X-ray diffraction (XRD)
Preliminary structural and morphological characterization was performed by X -Ray Diffraction (XRD) and Transmission Electron Microscopy (TEM). X -ray diffraction analysis was carried out on powder, at room temperature by using a Cu-K α radiation, in a SIEMENS D500 X-Ray diffractometer. The analysis has been performed with Jade 6.0 software. Fig. 1 presents the XRD patterns for «Sample -2» and «Sample -3». According to the XRD analysis, the peaks at 2θ=30. 20, 35.45, 43.32, 53.81 and 57.22º corresponds to the (220), (331), (400), (422) and (511) (220), the grain size for «Sample-1», «Sample-2», «Sample-3» and «Sample-4» was estimated to 10 nm, 13 nm, 9 nm and 11 nm respectively.
Transmission electron microscopy (TEM)
Particle size and crystallinity was also estimated from Transmission Electron Microscopy analysis using a JEOL 2010F Microscope. Fig. 2 presents the TEM micrographs of the «Sample-2» (Fig. 2a) and «Sample-3» (Fig. 2b) . Despite that every sample was ultrosonicated for 20 minutes in acetone before putting the drop on the grid, the nanoparticles seem to have a tendency for agglomeration, especially the nanoparticles of «Sample-3» which shows large agglomerates of about 100 nm. One reason for this tendency might be the magnetic interactions between the MNPs due to the usage of different surfactants in the sample synthesis. Another reason could be the inter-particle interactions which are quite large for the system. These images suggest that the shape of the nanoparticles is nearly spherical and by using SCION image software, and the respective sizes (mean diameters) were measured (8, 12, 6.5 and 9) ±20% nm, which is very close to the results calculated from the XRD analysis. Further, from the electron diffraction (ED) pattern which is internal image in Fig. 2a , the cubic structure of γ-Fe 2 O 3 is identified by indexing all the rings and confirmed the d-spacing corresponding to γ-Fe 2 O 3 phase.
XRD and TEM measurements suggest that the MNP's consist of γ-Fe 2 O 3 phase and pure, with a nearly spherical shape and susceptible agglomeration, especially for the «Sample-3», which as mentioned before affects the SAR, due to increase of the concentration of MNP's inside the ferrofluid.
Magnetic characterization of MNP's
Magnetic characterization of MNPs was performed by using the Vibrating Sample Magnetometry (VSM -1.2H/CF/HT Oxford Instruments VSM). According to hysteresis loops for all samples (Fig. 3) , all the samples are superparamagnetic due to the almost zero coercivity, and this is a desired property for MNP candidates for magnetic hyperthermia applications. Further, the saturation magnetization for the magnetic nanoparticles (M s ) is 54, 65, 10 and 57 emu g -1 for «Sample-1», «Sample-2», «Sample-3» and «Sample-4» respectively. (200), (311), (400), (422), (511) according to databases (JCPD-PDF #19-0629 for Magnetite and PDF #39-1346 for maghemite). 
Results and Discussion
Heating efficiency of MNP's under an AC external magnetic field
Hyperthermia response of MNP's
The heating efficiency of the nanoparticles in different concentrations was estimated in aqueous solutions. In order to approach the construction of the human body (concludes about 70% water), the MNPs dissolved in double distilled water, at four different concentrations, (0.25 -0.5 -1 -2) mg mL
. Further, the measurements were carried out in four different electric currents (7, 10, 14 and 18 A), which corresponds to magnetic fields (11.54-15.12-19.89 and 24.67 kA m -1 ). The frequency of the external AC magnetic field was set at 765 kHz and the generator of the field is of 4.5 kW and is connected to a three rounded coil, where the solution is placed. In each measurement, heating and cooling sequences were recorded for 900 s for each sequence. The signal from the double distilled water was first estimated in order to measure the signal resulting from the MNPs themselves, followed by the measurements of every aqueous sample (four concentration for every sample). The final stage was the calculation of the SAR index of every sample. Fig. 4 presents the heating efficiency of the initial signal of the double distilled water and the aqueous solutions including the MNPs. The heating signal from the double distilled water was first measured and used as the control signal in order to measure the heating efficiency of the MNPs themselves, by subtracting the control signal from the thermal response curves of the aqueous solutions. For every sample, the thermal response curves were measured at four different concentrations of the MNPs inside the aqueous solution (0.25-0.5-1 and 2 mg mL -1 ) except for the «Sample-1», where the dispersion of the MNPs at concentration 2 mg mL -1 inside the double distilled water was not satisfactory and measured at (0.25-0.5 and 1 mg mL -1 ). Further, the measurements were carried out in four different magnetic fields (11.54-15.12-19.89 and 24.67 kA m -1 ). Fig. 4a represents the thermal response curves of all aqueous solutions and the control signal at MNP's concentration 2 mg mL -1 (1 mg mL -1 for «Sample-1»), where the best results were achieved at magnetic field of 24.67 kA m -1 . Additionally, Fig. 4b , shows the thermal response of the MNP's themselves, after the control signal of double distilled water was subtracted. From Fig. 4 , it extracts that between the samples, «Sample-2» and «Sample-4» seems to have the best thermal response under an alternate magnetic field, with ΔΤ= 29 and 43ºC respectively.
SAR estimation
The amount of magnetic energy converted into heat (W) per time (Δt) and mass of the magnetic material (m mag ) is referred as specific absorption rate (SAR), and is given by:
(1) where (ΔΤ/Δt) is the initial slope of the heating curve as extracted from the experimental data, and Cp is the specific heat of the solution. Although the experimental setup was very well insulated and this insulation all around the sample reduces heat losses, the heat transfer with the environment is significant. In order to calculate the actual heating ability of the nanoparticles, the measurements were corrected by using the modified law of cooling, which is given by:
where T' is the temperature in an ideal stage of zero losses and k is a time constant, which is calculated using the cooling curve measured after removing the AC magnetic field. By fitting Eq. 2 to the heating curve, the temperature curve corresponding to the actual thermal energy produced by the MNPs is subtracted. SAR calculation of all samples was performed and the results are illustrated in Fig. 5 . As extract from these results, the increase of MNPs concentration beyond a limit seems to have a negative effect in SAR. This phenomenon can be attributed either to the fact that as the concentration of the MNP's increases in the ferrofluid, this has a negative effect to the Brownian and Neel relaxation losses due to aggregation of the MNP's. Further, there is also a possibility of reduced magnetic hysteresis due to dipolar coupling effects [52] .
Therefore, as concluded from the above analysis, it is obvious that every sample synthesized has its own properties (structural, magnetic and heating), and there is a strong difference between the properties of every sample. Fig. 6 illustrates the time dependence of temperature for all the samples of MNPs, when the temperature starts from basal body temperature at 37ºC. The side bands correspond to the desirable hyperthermia levels (42-46ºC). As indicated by these bands, «Sample-2» and «Sample-4» are sufficient for hyperthermia applications at an external field of 24.67 kA m -1 , while «Sample-1» and «Sample-3» are not. Further, Table 1 , offers a complete summary of all data on the properties of nanoparticles of all the samples. According to the above conclusions, «Sample -2» and «Sample -4» are overall more potential MNPs to be used as agents for in vitro magnetic hyperthermia applications, while possess two properties that satisfy this requirement: high-enough thermal efficiency and minimum treatment duration, and have chosen to be used in order to assess cytotoxicity, intracellular uptake and evaluation of the heating effect within cancer cell lines.
Cell culture, uptake assay and cytotoxicity assay
In vitro experiments
Three different types of cancer cell lines used, DA3, MCF-7 and HeLa, in order to assess cytotoxicity and measure the intracellular uptake of the «Sample -2» and «Sample -4» MNP's when they incorporated into the cell lines and finally to examine the heating process and effect of the «Sample -2» and «Sample -4» MNP's within the cancer cell lines.
Cell culture process
All cell lines were grown in trypsin and incubated at 37ºC in cell culture flasks. To control the impurity of the cell culture flasks, these flasks were observed under the optical microscope where the cells were checked for being healthy and confluent. Additional purification of the culture was achieved with pre-warmed PBS washing removes the loosely attached particles from the cell surface and also helps the effect of trypsin to become more potential. After washing with PBS, pre-warmed trypsin is added and then incubation for 15 minutes occurs. While the cells are incubating, the medium was removed from the plates and fresh medium added. Finally, the cells were transferred to a Nebauer plate in order to have an indirect measurement of the living cells. Then, the cell lines were incubated at 37ºC with 5% CO 2 for a day. After 24 h, the medium was changed, and a control of the culture under the microscope, concluded the cell culture procedure.
Uptake assay
After the culture of the cell lines were placed in culture flasks, the cells were transferred into 96 -well plates, and two well plates were prepared for each cell line. The number of cells per well was 10000 cell well -1 . MNPs of the samples «Sample -2» and «Sample -4», with solution concentration 2 mg mL -1 were added inside the wells with pipettes. The concentration of 2 mg mL -1 was chosen due to the very good thermal efficiency under an AC external field as mentioned in chapter 2.2.1. After the introduction of the MNPs, the samples were incubated for 24 h and 48 h respectively (this is the reason why two well plates were prepared for each cancer cell line). After incubation time, the samples were observed in the microscope in order for the endocytosis procedure to be concluded. Small rings around the cells were observed, which points a very specific way MNP endocytosis within the cells and concluded that endocytosis was reached. In order to assay the percentage of cells that have uptaken the magnetic nanoparticles, a magnetic cell separator used (MACS, by Miltenyi Biotech, Germany). The percentage was found to be 92-95% for both samples.
Cytotoxixity assay
After collecting the cells which have absorbed MNPs using a MAC separator, cytotoxicity tests were assessed using the Sulforhodamine B colorimetric assay (SRB), a method used for cell density determination, based on the measurement of cellular protein content [53, 54] and (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) assay (MTT), which mainly used for metabolism determination because MTT is reduced by active mitochondria in living cells and is a nonradioactive process [55, 56] . Each experiment was performed in triplicate in order to ensure the best reliability and reproducibility. In this study, the cell lines (DA-3, MCF-7 and HeLa) incubated with the MNPs of «Sample -2» and «Sample -4», were evaluated by SRB and MTT assay for two different time intervals: 24 and 48 h of incubation. Fig. 7 shows the results of both SRB and MTT tests in DA3 cell lines. The cells retained their viability for both 24 and 48 h in the experimental control. From the SRB results, it seems that for all cell lines incubated with both samples of MNPs, «Sample-2» and «Sample-4», the viability of the cell cultures is not significantly affected by the presence of the samples (97-98% viability in relation with the control samples). Further, from the MTT results, it is also notable that for a MNP's concentration of 2 mg mL -1 in the solution, the viability for HeLa cell line is about 50% for both 24 and 48 h of incubation. These results are in very good agreement with the results presented by Calmon et al. [57] . These data illustrate the viability of all the cell lines and suggest the potential use of MNPs in hyperthermia and general biomedical applications.
Magnetically mediated hyperthermia response
In vitro hyperthermia experiments in MNPs incorporated to cancer cell lines
The MNPs obtained for the in vitro magnetic hyperthermia experiments consist of nearly spherical shape with paramagnetic behavior at room temperature, exhibiting a cubic structure of γ-Fe 2 O 3 as presented in chapter 2.1., and no coatings around the nanoparticles exist. For the in vitro experiments, the AC external magnetic field has set at 26.48 kA m -1 , which corresponds to an electric current of 20 A. Further, all measurements were initiated from the temperature of 37ºC which is the basal body temperature and the time of reaching the temperature range of 42-46ºC was estimated for the MNPs of both samples incubated in DA3, MCF-7 and HeLa cell lines for 24 and 48 h of incubation. The heating efficiency of the control samples (only cell lines in medium) was also measured in order to conclude if the presence of MNP's helps the temperature to increase. Fig. 8 , illustrates the time dependence of the MNP's incorporated in DA3(8a), MCF-7 (8b) and HeLa (8c) cell lines, comparing to the control heating efficiency.
The observed temperature variation within the cancer cells is high enough to reach the desirable temperature levels for hyperthermia (42-46ºC) as indicated by the bands in Fig. 8 in less than 150 s. For the DA3 incorporated MNPs, it extracts that «Sample -2» incorporated for 48h seems to reach the desirable temperature in less than 125 s, while for the ΜCF-7 cell lines the «Sample -2» incorporated for 24 h seems to have better efficiency reaching the hyperthemia range very fast and the results are in great agreement with Aljarrah et al. [58] . For the HeLa cells, «Sample -4» incubated for 48 h, reaches the range of 42-46ºC at less than 120 s. It is also notable that the control sample (cells in the medium) also has fast thermal response under the AC alternate field and the temperature is inside the hyperthermia level, which corresponds to low cell viability at SRB and MTT assay as confirmed in chapter 2.4.2.
Control of the cells viability after magnetic hyperthermia measurements
After hyperthermia tests of MNPs incorporated to cancer cell lines were run, cell viability tests immediately started, in order to measure the percentage of cells destroyed by temperature increase due to magnetic hyperthermia. It is very crucial that viability tests are started immediately after hyperthermia, to avoid the exposure of the cells to various external factors which puts cells under further stress and further suffering. The viability tests were SRB and MTT protocols, as described in chapter 4.4. Fig. 9 , illustrates the results from the results of the SRB and MTT protocols for every cell line and the MNPs incorporated for 24 and 48 h. From the results, the percentage of the living cells after hyperthermia treatment has decreased dramatically. Cell death is due to an apoptotic mechanism which has been described [59] . It seems that the effect of the MNPs incorporated in MCF-7 cells has the best efficiency with viability percentage below 3.5% for every sample. The results are in agreement with other works [60] , which pointed out that even an increase of 0.5ºC in the cell culture can lead to apoptotic cell death.
Conclusions
In the current work, iron oxide nanoparticles (γ -Fe 2 O 3 and Fe 3 O 4 ), were synthesized and examined as possible magnetic hyperthermia agents in tumor therapy. Four samples were synthesized via wet synthesis, with different ingredients and reaction times. TEM, XRD and VSM measurements were performed in order to evaluate the shape, size and magnetic properties of the MNPs. Experimental hyperthermia heating was performed in all samples in double distilled aqueous solutions and the two most promising samples were selected in order to be used as agents for in vitro magnetic hyperthermia treatment in cancer cell lines. Three different cancer cell line were used (DA3, MCF-7 and HeLa), in order to assess cytotoxicity of the MNPs, estimate the cellular uptake and finally to measure the heating efficiency of the nanoparticles within cell lines. SRB and MTT test were performed after the cellular uptake of the MNPs, and extracted that the MNPs are biocompatible and the uptake was confirmed from the microscope measurements. In vitro magnetic hyperthermia measurements were performed in the cancer cell lines along with the developed MNPs, where the results pointed that the presence of the MNPs inside cells offers high enough heating efficiency and fast treatment duration. In vitro hyperthermia treatment was followed by SRB and MTT tests to evaluate the percentages of the viability of the cells and the best results were observed for «Sample -2» -48 h, uptaken from MCF-7 cells where the viability of cells after . Fig. 8a illustrates DA3 cell line incubated with MNP's of «Sample-2» and «Sample-4» for 24 and 48 h. Fig. Fig. 8b illustrates MCF-7 cell line incubated with MNP's of «Sample-2» and «Sample-4» for 24 and 48 h and Fig. 8c illustrates HeLa cell line incubated with MNP's of «Sample-2» and «Sample-4» for 24 and 48 h respectively. Bands indicate the desirable hyperthermia levels.
hyperthermia was 1.43%. In summary, the current study is a first step to in vitro characterization of magnetic hyperthermia in tumors. Further work is required in order the response of hyperthermia to improve and synthesizes novel MNPs, especially core -shell MNPs should be the priority, before in vivo application of hyperthermia.
